Genentech, UCSD Team Develop MS/MS-Based Method for De Novo Protein Sequencing

Researchers from the University of California, San Diego and Genentech have developed a mass spectrometry-based approach they said generates data that is nearly as accurate as Edman sequencing, but that takes a fraction of the time to generate. In addition, their technology offers significantly higher coverage than Edman sequencing and could open new ways for making higher-quality antibodies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.